Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2025JURNAL BIOLOGI TROPISOpen Access

Current Therapeutic Innovations in the Treatment of Von Willebrand Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

BPBaiq Bunga Citra PratiwiCSCantika Brilliant SennaMRMohammad Rizki

Discussion

Loading...

Member takes

Overview

Literature review highlights advances in hemostasis and diagnosis of Von Willebrand Disease, suggesting improved patient outcomes with tailored therapies.

Key Points

  • Antifibrinolytic agents like tranexamic acid improve management of Von Willebrand Disease, reducing bleeding risks substantially.
  • Recent advances in diagnostics and therapeutic options for Von Willebrand Disease drive personalized care approaches across various cases.
  • Observational analysis of perioperative management practices reveals the importance of multidisciplinary collaboration in treating bleeding disorders.
  • Effective diagnosis and management of Von Willebrand Disease can enhance overall patient quality of life despite ongoing treatment challenges.

Cite This Study

Pratiwi et al. (2025) studied this question.

synapsesocial.com/papers/690550001a99e50463de6adbhttps://doi.org/10.29303/jbt.v25i4.10359
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeting von Willebrand disease: the current status and future directions of management therapies2023 · 2 citations
  2. 2Past, Present, and Future of von Willebrand Disease2026
  3. 3Obstacles to Early Diagnosis and Treatment of Inherited von Willebrand Disease: Current Perspectives2021 · 11 citations
  4. 4Current controversies in the diagnosis and management of von Willebrand disease2015 · 15 citations
  5. 5Treatment of patients with von Willebrand disease2011 · 16 citations